ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

KALV KalVista Pharmaceuticals Inc

12.07
-0.19 (-1.55%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
KalVista Pharmaceuticals Inc KALV NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.19 -1.55% 12.07 13:00:14
始値 安値 高値 終値 前日終値
12.21 11.97 12.21 12.07 12.26
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1107:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0619:30BWKalVista Pharmaceuticals Presents Data at Eastern Allergy..
2024/6/0419:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
2024/6/0319:30BWKalVista Pharmaceuticals Presents Data on Persisting Unmet..
2024/6/0105:09BWKalVista Pharmaceuticals Announces New England Journal of..
2024/6/0101:15BWKalVista Pharmaceuticals Announces New England Journal of..
2024/5/2505:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2505:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2419:30BWKalVista Pharmaceuticals Announces Ten Abstracts Accepted..
2024/5/2206:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2206:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2206:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2206:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2119:30BWKalVista Pharmaceuticals to Present at Upcoming Investor..
2024/5/0219:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
2024/5/0119:30BWKalVista Pharmaceuticals Highlights Strategic Plans for..
2024/4/2219:30BWKalVista Pharmaceuticals Appoints William C. Fairey to Board..
2024/4/0319:30BWKalVista Pharmaceuticals to Present at 23rd Annual Needham..
2024/4/0219:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
2024/3/1819:30BWKalVista Pharmaceuticals Presents Real-World Data on Burden..
2024/3/1219:30BWKalVista Pharmaceuticals Awarded UK Promising Innovative..
2024/3/1205:37EDGAR2Form 8-K - Current report
2024/3/1205:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/3/1119:30BWKalVista Pharmaceuticals Reports Third Fiscal Quarter..
2024/3/0906:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0820:30BWKalVista Pharmaceuticals to Present HAE Attack Journey Data..
2024/3/0720:38EDGAR2Form 8-K - Current report
2024/3/0720:30BWKalVista Pharmaceuticals Announces Appointment of Benjamin..
2024/3/0620:30BWKalVista Pharmaceuticals to Participate in the Leerink..
2024/3/0420:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
2024/2/2720:30BWKalVista Pharmaceuticals Presents Data on Unmet Needs in HAE..
2024/2/2620:30BWKalVista Pharmaceuticals Presents Additional Phase 3..
2024/2/2306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2303:22EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/2/2211:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:49EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/2/2020:30BWKalVista Pharmaceuticals Awarded UK Innovation Passport for..
2024/2/1706:32EDGAR2Form 8-K - Current report
2024/2/1706:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/1706:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1620:30BWKalVista Pharmaceuticals to Present Phase 3 Sebetralstat..
2024/2/1520:30BWKalVista Pharmaceuticals Announces Pricing of a $160.1..
2024/2/1510:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..

最近閲覧した銘柄